QIANG TONG to Disease Progression
This is a "connection" page, showing publications QIANG TONG has written about Disease Progression.
Connection Strength
1.307
-
YY1 drives PARP1 expression essential for PARylation of NONO in mRNA maturation during neuroblastoma progression. J Transl Med. 2024 Dec 27; 22(1):1153.
Score: 0.574
-
Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression. Clin Transl Med. 2024 05; 14(5):e1680.
Score: 0.137
-
Therapeutic targeting of SPIB/SPI1-facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression. Clin Transl Med. 2021 11; 11(11):e588.
Score: 0.115
-
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression. J Hematol Oncol. 2020 03 26; 13(1):24.
Score: 0.103
-
Long Noncoding RNA NHEG1 Drives ?-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5. Mol Ther. 2020 03 04; 28(3):946-962.
Score: 0.102
-
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 2020; 10(4):1555-1571.
Score: 0.102
-
Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019 11 13; 18(1):158.
Score: 0.101
-
Targeting RBM10-Repressed RORB Activity in Liquid Condensates Inhibits Lysosomal Biogenesis and Neuroblastoma Progression via Affecting NF-?B Signaling. Adv Sci (Weinh). 2025 Nov; 12(44):e06131.
Score: 0.038
-
SNORA37/CMTR1/ELAVL1 feedback loop drives gastric cancer progression via facilitating?CD44 alternative splicing. J Exp Clin Cancer Res. 2025 Jan 16; 44(1):15.
Score: 0.036